230 related articles for article (PubMed ID: 18713853)
21. Substance P-induced trafficking of beta-arrestins. The role of beta-arrestins in endocytosis of the neurokinin-1 receptor.
McConalogue K; Déry O; Lovett M; Wong H; Walsh JH; Grady EF; Bunnett NW
J Biol Chem; 1999 Jun; 274(23):16257-68. PubMed ID: 10347182
[TBL] [Abstract][Full Text] [Related]
22. Extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase, through nuclear factor-kappaB and activator protein-1, contribute to caerulein-induced expression of substance P and neurokinin-1 receptors in pancreatic acinar cells.
Koh YH; Tamizhselvi R; Bhatia M
J Pharmacol Exp Ther; 2010 Mar; 332(3):940-8. PubMed ID: 20007404
[TBL] [Abstract][Full Text] [Related]
23. Detection of the full-length transcript variant for neurokinin-1 receptor in human whole blood associated with enhanced reinforcement of clot by substance-P.
Azma T; Sugimoto Y; Kinoshita H; Ito T; Tsukamoto M; Hoshijima H; Nakao M; Kikuchi H
J Thromb Thrombolysis; 2012 May; 33(4):329-37. PubMed ID: 22057425
[TBL] [Abstract][Full Text] [Related]
24. Dynamin and Rab5a-dependent trafficking and signaling of the neurokinin 1 receptor.
Schmidlin F; Dery O; DeFea KO; Slice L; Patierno S; Sternini C; Grady EF; Bunnett NW
J Biol Chem; 2001 Jul; 276(27):25427-37. PubMed ID: 11306580
[TBL] [Abstract][Full Text] [Related]
25. NK1R/5-HT1AR interaction is related to the regulation of melanogenesis.
Wu H; Zhao Y; Huang Q; Cai M; Pan Q; Fu M; An X; Xia Z; Liu M; Jin Y; He L; Shang J
FASEB J; 2018 Jun; 32(6):3193-3214. PubMed ID: 29430989
[TBL] [Abstract][Full Text] [Related]
26. Expression of different neurokinin-1 receptor (NK1R) isoforms in glioblastoma multiforme: potential implications for targeted therapy.
Cordier D; Gerber A; Kluba C; Bauman A; Hutter G; Mindt TL; Mariani L
Cancer Biother Radiopharm; 2014 Jun; 29(5):221-6. PubMed ID: 24552486
[TBL] [Abstract][Full Text] [Related]
27. MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.
Zhang L; Wang L; Dong D; Wang Z; Ji W; Yu M; Zhang F; Niu R; Zhou Y
Cell Prolif; 2019 Jan; 52(1):e12527. PubMed ID: 30334298
[TBL] [Abstract][Full Text] [Related]
28. Potential in vitro therapeutic effects of targeting SP/NK1R system in cervical cancer.
Mozafari M; Ebrahimi S; Darban RA; Hashemy SI
Mol Biol Rep; 2022 Feb; 49(2):1067-1076. PubMed ID: 34766230
[TBL] [Abstract][Full Text] [Related]
29. The SP/NK1R system promotes the proliferation of breast cancer cells through NF-κB-mediated inflammatory responses.
Jafarinezhad S; Assaran Darban R; Javid H; Hashemy SI
Cell Biochem Biophys; 2023 Dec; 81(4):787-794. PubMed ID: 37740877
[TBL] [Abstract][Full Text] [Related]
30. The third intracellular loop and carboxyl tail of neurokinin 1 and 3 receptors determine interactions with beta-arrestins.
Schmidlin F; Roosterman D; Bunnett NW
Am J Physiol Cell Physiol; 2003 Oct; 285(4):C945-58. PubMed ID: 12958028
[TBL] [Abstract][Full Text] [Related]
31. Substance P enhances the local activation of NK
Jeong YM; Cheng XW; Lee KH; Lee S; Cho H; Kim W
BMC Mol Cell Biol; 2020 Jun; 21(1):41. PubMed ID: 32517655
[TBL] [Abstract][Full Text] [Related]
32. Substance P excites GABAergic neurons in the mouse central amygdala through neurokinin 1 receptor activation.
Sosulina L; Strippel C; Romo-Parra H; Walter AL; Kanyshkova T; Sartori SB; Lange MD; Singewald N; Pape HC
J Neurophysiol; 2015 Oct; 114(4):2500-8. PubMed ID: 26334021
[TBL] [Abstract][Full Text] [Related]
33. New insight into the role of substance P/neurokinin-1 receptor system in breast cancer progression and its crosstalk with microRNAs.
Ebrahimi S; Javid H; Alaei A; Hashemy SI
Clin Genet; 2020 Oct; 98(4):322-330. PubMed ID: 32266968
[TBL] [Abstract][Full Text] [Related]
34. Substance P induces rapid and transient membrane blebbing in U373MG cells in a p21-activated kinase-dependent manner.
Meshki J; Douglas SD; Hu M; Leeman SE; Tuluc F
PLoS One; 2011; 6(9):e25332. PubMed ID: 21966499
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief.
Hegron A; Peach CJ; Tonello R; Seemann P; Teng S; Latorre R; Huebner H; Weikert D; Rientjes J; Veldhuis NA; Poole DP; Jensen DD; Thomsen ARB; Schmidt BL; Imlach WL; Gmeiner P; Bunnett NW
Proc Natl Acad Sci U S A; 2023 May; 120(22):e2220979120. PubMed ID: 37216510
[TBL] [Abstract][Full Text] [Related]
36. Tropisetron attenuates lipopolysaccharide induced neuroinflammation by inhibiting NF-κB and SP/NK1R signaling pathway.
Yu Y; Zhu W; Liang Q; Liu J; Yang X; Sun G
J Neuroimmunol; 2018 Jul; 320():80-86. PubMed ID: 29759144
[TBL] [Abstract][Full Text] [Related]
37. A mutation changes ligand selectivity and transmembrane signaling preference of the neurokinin-1 receptor.
Riitano D; Werge TM; Costa T
J Biol Chem; 1997 Mar; 272(12):7646-55. PubMed ID: 9065420
[TBL] [Abstract][Full Text] [Related]
38. The effect of CP96,345 on the expression of tachykinins and neurokinin receptors in acute pancreatitis.
Lau HY; Bhatia M
J Pathol; 2006 Feb; 208(3):364-71. PubMed ID: 16369913
[TBL] [Abstract][Full Text] [Related]
39. Improving NK1R-targeted gene delivery of stearyl-antimicrobial peptide CAMEL by conjugating it with substance P.
Song J; Huang S; Ma P; Zhang B; Jia B; Zhang W
Bioorg Med Chem Lett; 2020 Aug; 30(16):127353. PubMed ID: 32631551
[TBL] [Abstract][Full Text] [Related]
40. β-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G
Zhang YX; Li XF; Yuan GQ; Hu H; Song XY; Li JY; Miao XK; Zhou TX; Yang WL; Zhang XW; Mou LY; Wang R
J Biol Chem; 2017 May; 292(21):8933-8947. PubMed ID: 28341744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
